Sweden· SE-20240620000033
Oxibuprokain Bausch & Lomb 0,4 % (4 mg/ml) Ögondroppar, lösning i endosbehållare
A medicinal product containing oxybuprocaine hydrochloride, registered in Sweden by Ebb Medical AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Oxybuprocaine Hydrochloride
- Manufacturer
- Ebb Medical AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240620000033
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxybuprocaine hydrochloride in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMinims Oxybuprocaine HydrochlorideBausch + Lomb Ireland Limited
- NetherlandsMinims Oxybuprocainehydrochloride 4 mg/ml, oogdruppels, oplossingBausch + Lomb Ireland Limited
- CzechiaBENOXIUNIMED PHARMA spol. s r.o., Bratislava
- NorwayOxibuprokain MinimsBAUSCH + LOMB IRELAND LIMITED
- PolandNovainAGEPHA Pharma s.r.o.
- IcelandNovainAgepha Pharma s.r.o.
- FranceCHLORHYDRATE D'OXYBUPROCAINE THEA 1,6 mg/0,4 ml, collyre en récipient unidoseTHEA
- IrelandOxybuprocaine Agepha 4 mg/ml eye drops, solutionAGEPHA Pharma s.r.o.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Benoxinat Zur Anästhesie In Der Oto-Rhino-Laryngologie, Novain
- Belgium · Minims Oxybuprocaine Chlorhydrate Bausch + Lomb Ireland Limited, Minims Oxybuprocaïnehydrochloride Bausch + Lomb Ireland Limited
- Bulgaria · Бенокси
- Czechia · Benoxi, Oxybuprocaine Olikla
- Germany · Conjuncain® Edo®, Novesine
- Denmark · Oftasen, Oxybuprocainhydrochlorid Agepha
- Estonia · Novain
- Spain · Oxibuprocaína Hidrocloruro Agepha
- Finland · Minims, Obupro 4 Mg/Ml Silmätipat, Liuos
- France · Cebesine, Chlorhydrate D’oxybuprocaine Thea
- United Kingdom (Northern Ireland) · Oxybuprocaine Hydrochloride Alfa Intes
- Croatia · Ophtesia
- Hungary · Humacain, Oxybuprocaine Hydrochloride Agepha
- Ireland · Oxybuprocaine Agepha
- Iceland · Novain
- Italy · Benoxinato Cloridrato Intes, Novesina
- Lithuania · Novain
- Luxembourg · Conjuncain Edo, Minims
- Latvia · Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml
- Netherlands · Minims, Monofree
- Norway · Obupro, Oxibuprokain Minims Bausch + Lomb Ireland Limited
- Poland · Novain, 4 Mg/Ml,
- Portugal · Anestocil, Novain 4 Mg/Ml Colírio,
- Romania · Benoxi, Oftacain
- Slovakia · Benoxi, Oxybuprocaine Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5281595-da7d-4970-b4e4-d355a0e60735 GET /v1/drugs/f5281595-da7d-4970-b4e4-d355a0e60735?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20240620000033",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240620000033",
"product_doc_link": "https://docetp.mpa.se/LMF/Oxibuprokain%20Bausch%20%26%20Lomb%200.4%20%25%20%284%20mg%20per%20ml%29%20eye%20drops%2C%20solution%20in%20single-dose%20container%20IE%20PL_09001bee84327a41.pdf"
}See everything about oxybuprocaine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.